11. Oxybutynin as a treatment for generalized hyperhidrosis: a randomized, placebo‐controlled trial. (1st November 2015) Authors: Schollhammer, M.; Brenaut, E.; Menard‐Andivot, N.; Pillette‐Delarue, M.; Zagnoli, A.; Chassain‐Le Lay, M.; Sassolas, B.; Jouan, N.; Le Ru, Y.; Abasq‐Thomas, C.; Greco, M.; Penven, K.; Roguedas‐Contios, A.M.; Dupré‐Goetghebeur, D.; Gouedard, C.; Misery, L.; Le Gal, G. Journal: British journal of dermatology Issue: Volume 173:Number 5(2015:Nov.) Page Start: 1163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Personal vs. intrinsic melanoma risk awareness: results of the EDIFICE Melanoma survey. (February 2015) Authors: Robert, C.; Lebbe, C.; Ricard, S.; Saiag, P.; Grange, F.; Mortier, L.; Lhomel, C.; Sassolas, B. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29(2015)Supplement 2 Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Prevalence of sunbed use, and characteristics and knowledge of sunbed users: results from the French population‐based Edifice Melanoma survey. (February 2015) Authors: Grange, F.; Mortier, L.; Crine, A.; Robert, C.; Sassolas, B.; Lebbe, C.; Lhomel, C.; Saiag, P. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29(2015)Supplement 2 Page Start: 23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Preventability of SCARs. (1st August 2018) Authors: Chaby, G.; Valeyrie‐Allanore, L.; Duong, T.A.; Lebrun‐Vignes, B.; Milpied, B.; Sassolas, B.; Tetart, F.; Wolkenstein, P.; Chosidow, O.; Fardet, L. Journal: British journal of dermatology Issue: Volume 179:Number 2(2018) Page Start: e109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Preventability of SCARs. (24th August 2018) Authors: Chaby, G.; Valeyrie‐Allanore, L.; Duong, T.A.; Lebrun‐Vignes, B.; Milpied, B.; Sassolas, B.; Tetart, F.; Wolkenstein, P.; Chosidow, O.; Fardet, L. Journal: British journal of dermatology Issue: Volume 179:Number 2(2018) Page Start: e109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Prognosis of generalized bullous fixed drug eruption: comparison with Stevens–Johnson syndrome and toxic epidermal necrolysis. (16th February 2013) Authors: Lipowicz, S.; Sekula, P.; Ingen‐Housz‐Oro, S.; Liss, Y.; Sassolas, B.; Dunant, A.; Roujeau, J.‐C.; Mockenhaupt, M. Journal: British journal of dermatology Issue: Volume 168:Number 4(2013:Apr.) Page Start: 726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Real‐world treatment patterns and clinical outcomes in advanced cutaneous melanoma patients in France. (17th October 2017) Authors: Sassolas, B.; Leccia, M.T.; Godard, C.; Benmahamed, L.; Flinois, A.; Levy‐Bachelot, L.; Bédane, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 4(2018) Page Start: 587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect. (1st May 2020) Authors: Chen, D.M.; Odueyungbo, A.; Csinady, E.; Gearhart, L.; Lehane, P.; Cheu, M.; Maho‐Vaillant, M.; Prost‐Squarcioni, C.; Hebert, V.; Houivet, E.; Calbo, S.; Caillot, F.; Golinski, M.L.; Labeille, B.; Picard‐Dahan, C.; Paul, C.; Richard, M.A.; Bouaziz, J.D.; Duvert‐Lehembre, S.; Bernard, P. Journal: British journal of dermatology Issue: Volume 182:Number 5(2020) Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect. (28th November 2019) Authors: Chen, D.M.; Odueyungbo, A.; Csinady, E.; Gearhart, L.; Lehane, P.; Cheu, M.; Maho‐Vaillant, M.; Prost‐Squarcioni, C.; Hebert, V.; Houivet, E.; Calbo, S.; Caillot, F.; Golinski, M.L.; Labeille, B.; Picard‐Dahan, C.; Paul, C.; Richard, M.A.; Bouaziz, J.D.; Duvert‐Lehembre, S.; Bernard, P. Journal: British journal of dermatology Issue: Volume 182:Number 5(2020) Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Severe cutaneous adverse reactions due to inappropriate medication use. (1st August 2018) Authors: Chaby, G.; Valeyrie‐Allanore, L.; Duong, T.A.; Lebrun‐Vignes, B.; Milpied, B.; Sassolas, B.; Tetart, F.; Wolkenstein, P.; Chosidow, O.; Fardet, L. Journal: British journal of dermatology Issue: Volume 179:Number 2(2018) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗